ROCKWELL MEDICAL INC (RMTI) Fundamental Analysis & Valuation

NASDAQ:RMTI • US7743743004

Current stock price

1.03 USD
+0.01 (+0.98%)
Last:

This RMTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. RMTI Profitability Analysis

1.1 Basic Checks

  • RMTI had negative earnings in the past year.
  • In the past year RMTI has reported a negative cash flow from operations.
  • RMTI had negative earnings in each of the past 5 years.
  • RMTI had negative operating cash flow in 4 of the past 5 years.
RMTI Yearly Net Income VS EBIT VS OCF VS FCFRMTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • With a decent Return On Assets value of -9.60%, RMTI is doing good in the industry, outperforming 61.38% of the companies in the same industry.
  • The Return On Equity of RMTI (-14.90%) is better than 64.55% of its industry peers.
Industry RankSector Rank
ROA -9.6%
ROE -14.9%
ROIC N/A
ROA(3y)-19.01%
ROA(5y)-32.81%
ROE(3y)-57.83%
ROE(5y)-310.02%
ROIC(3y)N/A
ROIC(5y)N/A
RMTI Yearly ROA, ROE, ROICRMTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

  • RMTI has a worse Gross Margin (15.81%) than 78.84% of its industry peers.
  • In the last couple of years the Gross Margin of RMTI has grown nicely.
  • RMTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y30.04%
RMTI Yearly Profit, Operating, Gross MarginsRMTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. RMTI Health Analysis

2.1 Basic Checks

  • RMTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RMTI has been increased compared to 1 year ago.
  • RMTI has more shares outstanding than it did 5 years ago.
  • RMTI has a better debt/assets ratio than last year.
RMTI Yearly Shares OutstandingRMTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
RMTI Yearly Total Debt VS Total AssetsRMTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -6.97, we must say that RMTI is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -6.97, RMTI is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
  • RMTI has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
  • RMTI has a Debt to Equity ratio (0.26) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -6.97
ROIC/WACCN/A
WACC10.77%
RMTI Yearly LT Debt VS Equity VS FCFRMTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • RMTI has a Current Ratio of 3.92. This indicates that RMTI is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.92, RMTI is in the better half of the industry, outperforming 65.61% of the companies in the same industry.
  • RMTI has a Quick Ratio of 3.50. This indicates that RMTI is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.50, RMTI is in the better half of the industry, outperforming 68.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.92
Quick Ratio 3.5
RMTI Yearly Current Assets VS Current LiabilitesRMTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. RMTI Growth Analysis

3.1 Past

  • RMTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -213.73%.
  • Looking at the last year, RMTI shows a very negative growth in Revenue. The Revenue has decreased by -23.60% in the last year.
  • RMTI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.61% yearly.
EPS 1Y (TTM)-213.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-23.6%
Revenue growth 3Y17.9%
Revenue growth 5Y10.61%
Sales Q2Q%-43.75%

3.2 Future

  • RMTI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -24.78% yearly.
  • The Revenue is expected to decrease by -8.13% on average over the next years.
EPS Next Y-458.57%
EPS Next 2Y-63.45%
EPS Next 3Y-24.78%
EPS Next 5YN/A
Revenue Next Year-30.84%
Revenue Next 2Y-13.52%
Revenue Next 3Y-8.13%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RMTI Yearly Revenue VS EstimatesRMTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
RMTI Yearly EPS VS EstimatesRMTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. RMTI Valuation Analysis

4.1 Price/Earnings Ratio

  • RMTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year RMTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RMTI Price Earnings VS Forward Price EarningsRMTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RMTI Per share dataRMTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • RMTI's earnings are expected to decrease with -24.78% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.45%
EPS Next 3Y-24.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RMTI Dividend Analysis

5.1 Amount

  • RMTI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RMTI Fundamentals: All Metrics, Ratios and Statistics

ROCKWELL MEDICAL INC

NASDAQ:RMTI (3/24/2026, 12:12:33 PM)

1.03

+0.01 (+0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-26
Inst Owners8.92%
Inst Owner Change4.44%
Ins Owners4.19%
Ins Owner Change-0.12%
Market Cap40.59M
Revenue(TTM)75.58M
Net Income(TTM)-5.52M
Analysts82.5
Price Target3.83 (271.84%)
Short Float %2.5%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.49%
Min EPS beat(2)-8.93%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-45.86%
Min EPS beat(4)-198.04%
Max EPS beat(4)21.57%
EPS beat(8)5
Avg EPS beat(8)39.36%
EPS beat(12)8
Avg EPS beat(12)32.73%
EPS beat(16)12
Avg EPS beat(16)34.5%
Revenue beat(2)0
Avg Revenue beat(2)-3.69%
Min Revenue beat(2)-3.86%
Max Revenue beat(2)-3.53%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-3.86%
Max Revenue beat(4)6.2%
Revenue beat(8)5
Avg Revenue beat(8)1.8%
Revenue beat(12)8
Avg Revenue beat(12)2.62%
Revenue beat(16)9
Avg Revenue beat(16)0.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)150%
EPS NY rev (1m)25.81%
EPS NY rev (3m)34.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.54
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.92
BVpS0.94
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.6%
ROE -14.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.81%
FCFM N/A
ROA(3y)-19.01%
ROA(5y)-32.81%
ROE(3y)-57.83%
ROE(5y)-310.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y30.04%
F-Score3
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.88%
Cap/Sales 1.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.92
Quick Ratio 3.5
Altman-Z -6.97
F-Score3
WACC10.77%
ROIC/WACCN/A
Cap/Depr(3y)323.45%
Cap/Depr(5y)234.89%
Cap/Sales(3y)5.5%
Cap/Sales(5y)3.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-213.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-458.57%
EPS Next 2Y-63.45%
EPS Next 3Y-24.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.6%
Revenue growth 3Y17.9%
Revenue growth 5Y10.61%
Sales Q2Q%-43.75%
Revenue Next Year-30.84%
Revenue Next 2Y-13.52%
Revenue Next 3Y-8.13%
Revenue Next 5YN/A
EBIT growth 1Y-843.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-47.54%
EBIT Next 3Y26.47%
EBIT Next 5YN/A
FCF growth 1Y87.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.06%
OCF growth 3YN/A
OCF growth 5YN/A

ROCKWELL MEDICAL INC / RMTI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ROCKWELL MEDICAL INC (RMTI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to RMTI.


What is the valuation status of ROCKWELL MEDICAL INC (RMTI) stock?

ChartMill assigns a valuation rating of 0 / 10 to ROCKWELL MEDICAL INC (RMTI). This can be considered as Overvalued.


What is the profitability of RMTI stock?

ROCKWELL MEDICAL INC (RMTI) has a profitability rating of 2 / 10.


What is the financial health of ROCKWELL MEDICAL INC (RMTI) stock?

The financial health rating of ROCKWELL MEDICAL INC (RMTI) is 4 / 10.